Helicobacter pylori and extragastric diseases

Best Practice and Research: Clinical Gastroenterology

Volumn 21, Issue 2, 2007, Pages 325-334

  Franceschi, Francesco ^a   Gasbarrini, Antonio ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

autoimmunity; extragastric diseases; Helicobacter pylori

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; CAGA PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANGIOCARDIOGRAPHY; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY STENT; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENTEROPATHY; ERADICATION THERAPY; HEAD AND NECK DISEASE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMATOLOGIC DISEASE; HEPATOBILIARY DISEASE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IN VITRO STUDY; INTRAUTERINE GROWTH RETARDATION; IRON DEFICIENCY ANEMIA; ISCHEMIC HEART DISEASE; LUNG DISEASE; NONHUMAN; PATHOGENESIS; PILOT STUDY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; ROSACEA; SEROLOGY; STOMACH DISEASE; SYSTEMIC DISEASE; VIRUS STRAIN;

ATHEROSCLEROSIS; COMORBIDITY; DIGESTIVE SYSTEM DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEMATOLOGIC DISEASES; HUMANS;

EID: 33947224231     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2006.10.003     Document Type: Article

References (90)

1. Graham D.Y., and Go M.F. Helicobacter pylori: current status. Gastroenterology 105 (1993) 279-282
2. Correa P., Fox J., Fontham E., et al. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 66 (1990) 2569-2574
3. Isaacson P.G., and Spencer J. Gastric lymphoma and Helicobacter pylori. Important Adv Oncol (1996) 111-121
4. Carloni E., Cremonini F., Di Caro S., et al. Helicobacter pylori-related extradigestive diseases and effects of eradication therapy. Dig Liver Dis 32 supplement 3 (2000) S214-S216
5. Gasbarrini A., Franceschi F., Armuzzi A., et al. Extradigestive manifestations of Helicobacter pylori gastric infection. Gut 45 supplement 1 (1999) I9-I12
6. Mendall M.A., Goggin P.M., Molineaux N., et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71 (1994) 43-79
7. Danesh J., Wong Y., Ward M., et al. Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: population based study of coronary heart disease. Heart 81 (1999) 245-247
8. Alkout A.M., Ramsay E.J., Mackenzie D.A., et al. Quantitative assessment of IgG antibodies of Helicobacter pylori and outcome of ischaemic heart disease. FEMS Immunol Med Microbiol 29 (2002) 271-274
9. Pellicano R., Mazzarello M.G., Morelloni S., et al. Acute myocardial infarction and Helicobacter pylori seropositivity. Int J Clin Lab Res 29 (1999) 141-144
10. Danesh J., Youngman L., Clark S., et al. Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study. BMJ 319 (1999) 1157-1162
11. Gorunovsiaia I.G. Features of ulcer disease in elderly patients with ischaemic heart disease. Eksp Klin Gastroenterol 117 (2002) 16-21
12. Yamaoka Y., El-Zimaity H.M., Gutierrez O., et al. Relationship between the cagA 3′ repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology 117 (1999) 342-349
13. Gunn M., Stephens J.C., Thompson J.R., et al. Significant association of Cag-A positive Helicobacter pylori strains with risk of premature myocardial infarction. Heart 84 (2000) 267-271
14. Gasbarrini A., Serricchio M., Tondi P., et al. Helicobacter pylori infection and vascular diseases. Ital J Gastroenterol Hepatol 30 supplement 3 (1998) S307-S309
15. Kowalski M., Konturek P.C., Pieniazek P., et al. Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty. Dig Liver Dis 33 (2001) 222-229
16. Pasceri V., Cammarota G., Patti G., et al. Association of virulent Helicobacter pylori strains with ischaemic heart disease. Circulation 97 (1998) 1675-1679
17. Singh R.K., McMahon A.D., Patel H., et al. Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease. Heart 88 (2002) 43-46
18. Pietroiusti A., Diomedi M., Silvestrini M., et al. Cytotoxin associated gene-A-positive Helicobacter pylori strains are associated with atherosclerotic stroke. Circulation 106 (2002) 580-584
19. Majka J., Rog T., Konturek P.C., et al. Influence of chronic Helicobacter pylori infection on ischaemic cerebral stroke risk factors. Med Sci Monit 8 (2002) CR675-CR684
20. Gabrielli M., Santoliquido A., Cremonini F., et al. CagA-positive cytotoxic H. pylori strains as a link between plaque instability and atherosclerotic stroke. Eur Heart J 25 (2004) 64-68
21. Zito F., Di Castelnuovo A., D'Orazio A., et al. Helicobacter pylori infection and the risk of myocardial infarction: role of fibrinogen and its genetic control. Thromb Haemost 82 (1999) 14-18
22. Hoffmeister A., Rothenbacher D., Bode G., et al. Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile. Arterioscler Thromb Vasc Biol 21 (2001) 427-432
23. Schumacher A., Seljeflot I., Lerkerod A.B., et al. Positive Chlamydia pneumoniae serology is associated with elevated levels of tumor necrosis factor alpha in patients with coronary heart disease. Atherosclerosis 164 (2002) 153-160
24. Ameriso S.F., Fridman E.A., Leiguarda R.C., et al. Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 32 (2001) 385-391
25. Kowalski M., Rees W., Konturek P.C., et al. Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina. Dig Liver Dis 34 (2002) 398-402
26. Kowalski M. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. J Physiol Pharmacol 52 supplement 1 (2001) 3-31
27. Schumacher A., Seljeflot I., Lerkerod A.B., et al. Does infection with Chlamydia pneumoniae and/or Helicobacter pylori increase the expression of endothelial cell adhesion molecules in humans?. Clin Microbiol Infect 8 (2002) 654-661
28. Xu Q., Schett G., Perschinka H., et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 102 (2000) 14-20
29. Birnie D.H., Holme E.R., McKay I.C., et al. Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of 'Helicobacter pylori' and other bacterial infections in increasing cardiovascular risk. Eur Heart J 19 (1998) 387-394
30. Roivainen M., Viik-Kajander M., Palosuo T., et al. Infections, inflammation, and the risk of coronary heart disease. Circulation 101 (2000) 252-257
31. Laurila A., Bloigu A., Nayha S., et al. Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis 142 (1999) 207-210
32. Bielanski W. Epidemiological study on Helicobacter pylori infection and extragastroduodenal disorders in Polish population. J Physiol Pharmacol 50 (1999) 723-733
33. Quinn M.J., Foley J.B., Mulvihill N.T., et al. Helicobacter pylori serology in patients with angiographically documented coronary artery disease. Am J Cardiol 83 (1999) 1664-1666
34. Tasi C.J., and Huang T.Y. Relation of Helicobacter pylori infection and angiographically demonstrated coronary artery disease. Dig Dis Sci 45 (2000) 1227-1232
35. Pieniazek P., Karczewska E., Duda A., et al. Association of Helicobacter pylori infection with coronary heart disease. J Physiol Pharmacol 50 (1999) 743-751
36. Carlsson J., Miketic S., Brom J., et al. Prior cytomegalovirsu, Chlamydia pneumoniae or Helicobacter pylori infection and the risk of restenosis after percutaneous transluminal coronary angioplasty. Int J Cardiol 73 (2000) 165-171
37. Schiele F., Batur M.K., Seronde M.F., et al. Cytomegalovirus, Chlamydia pneumoniae and Helicobacter pylori IgG antibodies and restenosis after stents implantation: an angiographic and intravascular ultrasound study. Heart 85 (2001) 304-311
38. Danesh J., Koreth J., Youngman L., et al. Is Helicobacter pylori a factor in coronary atherosclerosis?. J Clin Microbiol 37 (1999) 1651
39. Murray L.J., Bamford K.B., Kee F., et al. Infection with virulent strains of Helicobacter pylori is not associated with ischaemic heart disease: evidence from a population-based case-control study of myocardial infarction. Atherosclerosis 149 (2000) 379-385
40. Franceschi F., Sepulveda A.R., Gasbarrini A., et al. Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation 106 (2002) 430-434
41. Danesh J., and Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. Biomed J 346 (1998) 1130-1132
42. Schweeger I., Fitscha P., and Sinzinger H. Successful eradication of Helicobacter pylori as determined by 13C-urea breath test does not alter fibrinogen and acute phase response markers. Thromb Res 97 (2000) 411-420
43. Yusuf S.W., and Mishra R.M. Effect of Helicobacter pylori infection on fibrinogen level in elderly patients with ischaemic heart disease. Acta Cardiol 57 (2002) 317-322
44. Parente F., Imbesi V., Cucino C., et al. Helicobacter pylori CagA seropositivity does not influence inflammatory parameters, lipid concentrations and haemostatic factors in healthy individuals. J Intern Med 247 (2000) 213-217
45. Rothenbacher D., Hoffmeister A., Bode G., et al. Helicobacter pylori heat shock protein 60 and risk of coronary heart disease: a case control study with focus on markers of systemic inflammation and lipids. Atherosclerosis 156 (2001) 193-199
46. Fukuda K., Kuroki T., Tajima Y., et al. Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer. Carcinogenesis 23 (2002) 1927-1931
47. Kuroki T., Fukuda K., Yamanouchi K., et al. Helicobacter pylori accelerates the biliary epithelial cell proliferation activity in hepatolithiasis. Hepatogastroenterology 49 (2002) 648-651
48. Bulajic M., Maisonneuve P., Schneider-Brachert W., et al. Helicobacter pylori and the risk of benign and malignant biliary tract disease. Cancer 95 (2002) 1946-1953
49. Fallone C.A., Chiba N., and Buchan A. Two decades of Helicobacter pylori: a review of the Fourth Western Pacific Helicobacter Congress. Can J Gastroenterol 16 (2002) 559-563
50. Fujimori S., Kishida T., Kobayashi T., et al. Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women. J Gastroenterol 40 (2005) 887-893
51. Mizuno S., Morita Y., Inui T., et al. Helicobacter pylori infection is associated with colon adenomatous polyps detected by high-resolution colonoscopy. Int J Cancer 117 (2005) 1058-1059
52. Gasbarrini A., Franceschi F., Tartaglione R., et al. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 352 (1998) 878
53. Hino M., Yamane T., Park K., et al. Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura. Ann Hematol 82 (2003) 30-32
54. Kohda K., Kuga T., Kogawa K., et al. Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. Br J Haematol 118 (2002) 584-588
55. Veneri D., Franchini M., Gottardi M., et al. Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura. Haematologica 87 (2002) 1177-1179
56. Huber M.R., Kumar S., and Tefferi A. Treatment advances in adult immune thrombocytopenic purpura. Ann Hematol 82 (2003) 723-737
57. Franceschi F., Christodoulides N., Kroll M.H., et al. Helicobacter pylori and idiopathic thrombocytopenic purpura. Ann Intern Med 140 (2004) 766-767
58. Fukuda S., Shimoyama T., Umegaki N., et al. Effect of Helicobacter pylori eradication in the treatment of Japanese patients with chronic idiopathic urticaria. J Gastroenterol 39 (2004) 827-830
59. Annibale B., Capurso G., Lahner E., et al. Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia. Gut 52 (2003) 496-501
60. Seo J.K., Ko J.S., Choi K.D., et al. Serum ferritin and Helicobacter pylori infection in children: a sero-epidemiologic study in Korea. J Gastroenterol Hepatol 17 (2002) 754-757
61. Sugiyama T., Tsuchida M., and Yokota K. Improvement of long-standing iron-deficiency anemia in adults after eradication of Helicobacter pylori infection. Intern Med 41 (2002) 491-494
62. Choe Y.H., Kim S.K., Hong Y.C., et al. The relationship between Helicobacter pylori infection and iron deficiency: seroprevalence study in 937 pubescent children. Arch Dis Child 88 (2003) 178
63. Kostaki M., Fessatou S., Karpathios T., et al. Refractory iron-deficiency anaemia due to silent Helicobacter pylori gastritis in children. Eur J Pediatr 162 (2003) 177-179
64. Malik A.A., Ganti A.K., Potti A., et al. Role of Helicobacter pylori infection in the incidence and clinical course of monoclonal gammopathy of undetermined significance. Am J Gastroenterol 97 (2002) 1371-1374
65. Rajkumar S.V., Kyle R.A., Plevak M.F., et al. Helicobacter pylori infection and monoclonal gammopathy of undetermined significance. Br J Haematol 119 (2002) 706-708
66. Caselli M., Zaffoni E., Ruina M., et al. Helicobacter pylori and chronic bronchitis. Scand J Gastroenterol 34 (1999) 828-830
67. Kanbay M., Gur G., Akcay S., et al. Helicobacter pylori seroprevalence in patients with chronic bronchitis. Respir Med 99 (2005) 1213-1216
68. Gencer M., Ceylan E., Yildiz Zeyrek F., et al. Helicobacter pylori seroprevalence in patients with chronic obstructive pulmonary disease and its relation to pulmonary function tests. Respiration (2005) Dec 6 [Epub ahead of print]
69. Ece F., Hatabay N.F., Erdal N., et al. Does Helicobacter pylori infection play a role in lung cancer?. Respir Med 99 (2005) 1258-1262
70. Jun Z.J., Lei Y., Shimizu Y., et al. Helicobacter pylori seroprevalence in patients with mild asthma. Tohoku J Exp Med 207 (2005) 287-291
71. Otasevic L., Walduck A., Meyer T.F., et al. Helicobacter pylori infection in anterior uveitis. Infection 33 (2005) 82-85
72. Sacca S.C., Pascotto A., Venturino G.M., et al. Prevalence and treatment of Helicobacter pylori in patients with blepharitis. Invest Ophthalmol Vis Sci 47 (2006) 501-508
73. Morinaka S., Tominaga M., and Nakamura H. Detection of Helicobacter pylori in the middle ear fluid of patients with otitis media with effusion. Otolaryngol Head Neck Surg 133 (2005) 791-794
74. Yilmaz M.D., Aktepe O., Cetinkol Y., et al. Does Helicobacter pylori have role in development of otitis media with effusion?. Int J Pediatr Otorhinolaryngol 69 (2005) 745-749
75. Kutluhan A., Yurttas V., Akarca U.S., et al. Possible role of Helicobacter pylori in the etiopathogenesis of chronic otitis media. Otol Neurotol 26 (2005) 1125-1127
76. Schulz J.D., Hawkes E.L., and Shaw C.A. Cycad toxins, Helicobacter pylori and parkinsonism: cholesterol glucosides as the common denomenator. Med Hypotheses 66 (2006) 1222-1226
77. Weller C., Charlett A., Oxlade N.L., et al. Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 3: predicted probability and gradients of severity of idiopathic parkinsonism based on H. pylori antibody profile. Helicobacter 10 (2005) 288-297
78. Di Campli C., Gasbarrini A., Nucera E., et al. Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci 43 (1998) 1226-1229
79. Gasbarrini A., and Franceschi F. Does H. pylori infection play a role in idiopathic thrombocytopenic purpura and in other autoimmune diseases?. Am J Gastroenterol 100 (2005) 1271-1273
80. Szlachcic A. The link between Helicobacter pylori infection and rosacea. J Eur Acad Dermatol Venereol 16 (2002) 328-333
81. Kazerooni T., Taallom M., Ghaderi A.A., et al. Helicobacter pylori seropositivity in patients with hyperemesis gravidarum. Int J Gynaecol Obstet 79 (2002) 217-220
82. Salimi-Khayati A., Sharami H., Mansour-Ghanaei F., et al. Helicobacter pylori seropositivity and the incidence of hyperemesis gravidarum. Med Sci Monit 9 (2003) CR12-CR52
83. Bagis T., Gumurdulu Y., Kayaselcuk F., et al. Endoscopy in hyperemesis gravidarum and Helicobacter pylori infection. Int J Gynaecol Obstet 7 (2002) 105-109
84. Eslick G.D., Yan P., Xia H.H., et al. Foetal intrauterine growth restrictions with Helicobacter pylori infection. Aliment Pharmacol Ther 16 (2002) 1677-1682
85. Ertem D., and Pehlivanoglu E. Helicobacter pylori may influence height in children independent of socioeconomic factors. J Pediatr Gastroenterol Nutr 35 (2002) 232-233
86. Takahashi M., Kimura H., Watanabe K., et al. Helicobacter pylori infection in patients with idiopathic short stature. Pediatr Int 44 (2002) 277-280
87. Passaro D.J., Taylor D.N., Gilman R.H., et al. Growth slowing after acute Helicobacter pylori infection is age-dependent. J Pediatr Gastroenterol Nutr 35 (2002) 522-526
88. Furuta T., Shirai N., Xiao F., et al. Effect of Helicobacter pylori infection and its eradication on nutrition. Aliment Pharmacol Ther 16 (2002) 799-806
89. Figura N., Piomboni P., Ponzetto A., et al. Helicobacter pylori infection and infertility. Eur J Gastroenterol Hepatol 14 (2002) 663-669
90. Zentilin P., Seriolo B., and Dulbecco P. Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritis. Aliment Pharmacol Ther 16 (2002) 1291-1299